Solvay held a webinar for the investment community on its Performance Chemicals business

Brussels, June 25, 2024, 5.45 pm CEST

Solvay’s management today held a webinar on its Performance Chemicals segment, which includes the Silica, Special Chem and Coatis business units. These activities produce additives and ingredients that are essential to the daily lives of the people.

Management set out how Solvay’s Performance Chemicals segment (40% of Solvay 2023 net sales) shares common value creation drivers with Solvay’s other business units from a Commercial, Innovation, Quality of Assets or Supply Chain perspective.

Furthermore, the webinar demonstrated the proven track record and resilience of cash generation of the Performance Chemicals business, delivering EBITDA growth of more than 4% and an average cash conversion ratio above 70% over the past 5 years. This was driven by:

• Exposure to end-markets with strong megatrends

• Leveraging a group of business lines with either global or regional leadership

• Maintaining leadership in process innovation and applying strict cost discipline

• Operating a group of less Capex intensive business lines when compared to Solvay’s Basic Chemicals segment

A replay of this webinar is available on Solvay’s Investor Relations website. In the same section, you will also find the replay of the previous webinar on the Peroxides and Soda ash & Derivatives webinars, respectively held in October 2022 and February 2023.

Contacts

Safe harbor

This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.